Free Submission Public Relations &
Deutsch English


India set to become leading API manufacturer

Print article Print article

2014-02-13 11:49:26 - Is India poised to become a leader in API manufacturing?

The Active Pharmaceutical Ingredient (API) industry is growing due to increasing demand from emerging markets. Though India is currently a global API manufacturer of some importance, issues concerning quality, proper infrastructure and differential laws within the country have held back its potential. Will India overcome these concerns and maintain its competitiveness in global markets? Catherine Tang, Business Development Director, Biomedical of Spire Research and Consulting, shared her thoughts in Express Pharma Magazine India.

India is poised to become a hub for API production, as the total expenditure on drugs worldwide is set to increase. Besides, healthcare reforms and impending patent cliffs in the developed markets of Europe and the US are presenting new opportunities for API manufacturers. However, India is threatened

by export barriers and rising inspection checks, which could raise manufacturing costs and crimp profit margins.

Tang remarked that there should be emphasis on quality assurance, and a branding strategy should be adopted to overcome the limitations of the current low-cost value proposition. With an increase in Food and Drug Administration (FDA) inspections of overseas production sites, Indian API producers should invest in information management systems that will optimize workflow, provide improved quality metrics and ensure adequacy of audit trails.

At the same time, the infrastructure for inbound logistics should be improved to maintain competitiveness. Manufacturers should be less dependent on import of materials from other countries, and the government should be more supportive by extending tax support for process automation.

Meanwhile, India also needs to resolve issues with its legal framework. Pharma laws and regulations need to become better aligned with global best practices so as to benefit manufacturers. This will eventually boost global customers’ confidence in the “Made-in-India” label.

Press Information:
Spire Research and Consulting Pte Ltd

Unit 501-502, DLF City Court, DLF Phase III, Sector-24, Gurgaon - 122 002

Contact Person:
Nidhi Singh
Executive - Corporate Communications
Phone: (91) 124 421 6144
email: email


Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact